Living with or without cyclins and cyclin-dependent kinases
Open accessThe DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Entry into, progression through, and exit from the G1 phase of the mammalian cell cycle in response to extracellular mitogenic cues are presumed to be governed by cyclin-dependent kinases (Cdks) regulated by the D-type and E-type cyclins. Studies performed over more than a decade have supported the view that these holoenzymes are important, if not required, for these processes. However, recent experiments in which the genes encoding all three D-type cyclins, the two E-type cyclins, cyclin D-dependent Cdk4 and Cdk6, or cyclin E-dependent Cdk2 have been disrupted in the mouse germ line have revealed that much of fetal development occurs normally in their absence. Thus, none of these genes is strictly essential for cell cycle progression. To what extent is the prevailing dogma incorrect, and how can the recent findings be reconciled with past work?
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Despite the high frequency of mutations epistatically targeting the RB signaling pathway in cancer cells, inactivation of the individual cyclin D, Cdk4/6, and Ink4a genes in mice, while leading to specific developmental defects when disrupted alone or in combination, established that their functions were nonessential for the cell cycle per se (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it may well prove that mutations affecting other cell cycle regulators, such as amplification of cyclin E, loss of p27Kip1 or p21Cip1 and activation of CDK2 would bypass the requirement of tumor cells for CDK4/6 activity, thereby also conferring de novo resistance (62-64).”
From Targeting CDK4 and CDK6: From Discovery to Therapy (2016) · cites this paper as [63]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370 · cited 1×
“…the idea that mutant " cancer stem cells, " rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance and, in turn, for resistance to therapy (Reya et al. 2001; Taipale and Beachy 2001; Al-Hajj et al. 2003).”
BackgroundStem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738 · cited 2×
“The cells that give rise to many cancers have both the self-renewal and differentiating capacities of tissue stem cells, raising the idea that mutant “cancer stem cells,” rather than their differentiated progeny that may make up the bulk of a tumor, are the only cells strictly responsible for durable tumor maintenance…”
BackgroundCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115 · cited 1×
“The AKT kinase controls the subcellular localization of Cip/Kip proteins as well (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002), providing yet another avenue for cyclin E–Cdk2 regulation in response to extracellular cues.”
BackgroundSelf-citationA new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“1994); conversely, attenuation of Cdk4 activity by polypeptide inhibitors of the INK4 gene family (Serrano et al. 1993) or by Cdk4-selective drugs (Tetsu and McCormick 2003) results in G1-phase arrest and cell cycle exit.”
BackgroundInhibitors of mammalian G1 cyclin-dependent kinases.
Sherr, C. J., & Roberts, J. M. (1995) · Genes & Development · doi:10.1101/gad.9.10.1149 · Cited by 3,243 · cited 6×
“1993), and by induction of polypeptide inhibitors of the Cip/Kip family in many physiologic settings (Sherr and Roberts 1995) result in G1-phase arrest.”
BackgroundInfluentialSelf-citationG1 phase progression: Cycling on cue
Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90540-1 · Cited by 2,674 · cited 1×
“If this occurs before the G1/S boundary, cells exit the cycle without replicating their DNA, but if it occurs afterward, cells complete mitosis and exit from the cycle in the next G1 interval (Matsushime et al. 1994; Sherr 1994).”
BackgroundSelf-citationCYCLIN-DEPENDENT KINASES: Engines, Clocks, and Microprocessors
Morgan, D. O. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.261 · Cited by 2,259 · cited 3×
“The relevant proteins include three D-type cyclins (D1, D2, and D3) that, in different combinations, bind to, and allosterically regulate, one of two Cdk subunits, Cdk4 and Cdk6, as well as the E-type cyclins (E1 and E2), which, in analogous fashion, govern the activity of a single catalytic subunit, Cdk2 (Morgan 1997…”
BackgroundInfluentialGlycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization
Diehl, J. A., Cheng, M., Roussel, M. F., & Sherr, C. J. (1998) · Genes & Development · doi:10.1101/gad.12.22.3499 · Cited by 2,130 · cited 2×
“…GSK-3, an enzyme that is inhibited by the phosphatidylinositol 3-kinase/AKT signaling pathway , in determining the stability of cyclin E implies that its life history, like that of cyclin D1 (Diehl et al. 1998), can be directly influenced by at least one mitogen-dependent kinase signaling cascade.”
BackgroundSelf-citationPolyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954 · cited 1×
“, two potent inhibitors of Cdk2 (Polyak et al. 1994; Reynisdottir et al. 1995; Sherr and Roberts 1995).”
Self-citationCyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614 · cited 2×
“In continuously dividing cells, cyclin D1 exits the cell nucleus during S phase, and its turnover is accelerated throughout this interval (Baldin et al. 1993; Diehl et al. 1998), but Rasdependent cyclin D1 synthesis and its stabilization in G2 phase allow it to reaccumulate before cells divide (Guo…”
Background
Research works printed but not linked: 1
- Resnitzky, D., Gossen, M., Bujard, H., and Reed, S.I. 1994. Ac- celeration of the G1/S phase transition by expression of cy- clins D1 and E with an inducible system. Mol. Cell. Biol. 14: 1669-1679.
Cited by
Items 401–500 of 1,000
Kanatsu‐Shinohara, M., Takashima, S., & Shinohara, T. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914448107 · Cited by 38
“Two families of CDKIs promote cell cycle withdrawal by blocking the activity of cyclin/CDK complexes: the Cip/Kip family, including p21, p27, and p57, and the INK4 family, including p15, p16, p18, and p19 (5).”
BackgroundCyclin D1 in excitatory neurons of the adult brain enhances kainate-induced neurotoxicity
Koeller, H. B., Ross, M. E., & Glickstein, S. B. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.04.010 · Cited by 40
“D-type cyclins (cD1, cD2, cD3) are positive regulators of the midG1-transition — the only point in the cycle when a cell can commit to another round of division or exit the cell cycle (Sherr and Roberts, 2004).”
BackgroundMcGowan, E. M., Russell, A. J., Boonyaratanakornkit, V., Saunders, D. N., Lehrbach, G. M., Sergio, C. M., Musgrove, E. A., Edwards, D. P., & Sutherland, R. L. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1255 · Cited by 39
“exit from quiescence and the deregulated cell cycles of cancer cells (46), and that cyclin D1 is a critical element of progestin regulation of breast cancer cell proliferation (31, 40, 41).”
Scholz, A., Wagner, K. G., Welzel, M., Remlinger, F., Wiedenmann, B., Siemeister, G., Rosewicz, S., & Detjen, K. M. (2008) · Gut · doi:10.1136/gut.2007.146415 · Cited by 42
Tight function zonula occludens-3 regulates cyclin D1–dependent cell proliferation
Capaldo, C., Koch, S., Kwon, M., Laur, O., Parkos, C. A., & Nusrat, A. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-08-0677 · Cited by 45
“RESULTS Cyclin D1 colocalizes with the TJ plaque protein ZO-1 Cyclin D1 is a key promoter of G1-S phase transition and a major regulator of cell proliferation (Malumbres and Barbacid, 2001; Balda et al., 2003; Sherr and Roberts, 2004).”
BackgroundZhang, S., Sheng, H., Zhang, X., Qi, Q., Chan, C. B., Li, L., Shan, C., & Ye, K. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1452-1 · Cited by 39
Lan, K., Choudhuri, T., Murakami, M., Kuppers, D. A., & Robertson, E. S. (2006) · Journal of Virology · doi:10.1128/jvi.00239-06 · Cited by 38
“This provides a possible explanation for the ICN-mediated increase in proliferation of KSHV-positive cells, as cyclin D1 is a major regulator of the G1/S transition (46).”
BackgroundSaini, M. K., & Sanyal, S. N. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1015743 · Cited by 37
“Accordingly, cyclin-dependent kinase (CDK) family is found crucial in the transition from normal to tumor cell cycle, each member of which, as the name reveals, is dependent on a distinct protein partner, or cyclin for their activation (3,4).”
BackgroundLaphanuwat, P., Likasitwatanakul, P., Sittithumcharee, G., Thaphaengphan, A., Chomanee, N., Suppramote, O., Ketaroonrut, N., Charngkaew, K., Lam, E. W. ‐., Okada, S., et al. (2018) · Journal of Cell Science · doi:10.1242/jcs.214726 · Cited by 43
“Cyclin D1 is a cell cycle regulatory protein, which is amplified and overexpressed in a large number of human cancers (Sukov et al., 2009; Musgrove et al., 2011; Lee et al., 2016).”
BackgroundCyclin C: The Story of a Non-Cycling Cyclin
Ježek, J., Smethurst, D. G. J., Stieg, D. C., Kiss, Z., Hanley, S. E., Ganesan, V., Chang, K., Cooper, K. F., & Strich, R. (2019) · Biology · doi:10.3390/biology8010003 · Cited by 43
“Previous studies have noted that deleting all three D-type cyclins or the two cyclin E isoforms that reported control G1 progression or the G1-S phase transition are largely dispensable for mouse development [41], leading to the notion that other cyclin family members can provide cell cycle regulatory functions.”
Ding, H., Luo, Y., Hu, K., Liu, P., & Xiong, M. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207748 · Cited by 37
“The cyclin D-CDK4/6 complex leads to G0/G1-S phase transition through two distinguished mechanisms.(6) It may eliminate inhibition of two CDK inhibitors p21 and p27, which results in activation of cyclin E-CDK2.”
BackgroundYang, B., Du, K., Yang, C., Xiang, L., Xu, Y., Chen, C., Zhang, J., & Liu, W. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15019 · Cited by 42
Torrieri, G., Ferreira, M. P. A., Shahbazi, M., Talman, V., Karhu, S. T., Pohjolainen, L., Carvalho, C., Pinto, J. F., Hirvonen, J. J., Ruskoaho, H. J., et al. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202109032 · Cited by 37
p53 and Myofibroblast Apoptosis in Organ Fibrosis
McElhinney, K., Irnaten, M., & O'Brien, C. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076737 · Cited by 39
“p53 stimulates p21 transcription [82]—a cyclindependent kinases (CDK) inhibitor of G1-CDK-cyclin complexes (CDK2-cyclin-E, CDK4cyclin-D), and CDK1-cyclin-B complexes [83,84].”
BackgroundRole of Fgf10 in cell proliferation in white adipose tissue
Konishi, M., Asaki, T., Koike, N., Miwa, H., Miyake, A., & Itoh, N. (2006) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2006.01.010 · Cited by 37
Raif, A., Marshall, G. M., Bell, J. L., Koach, J., Tan, O., D'Andreti, C., Thomas, W. D., Sekyere, E. O., Norris, M. D., Haber, M., et al. (2009) · Cancer Letters · doi:10.1016/j.canlet.2008.11.030 · Cited by 37
Hepatic retinoid stores are required for normal liver regeneration
Shmarakov, I. O., Jiang, H., Yang, K. J. Z., Goldberg, I. J., & Blaner, W. S. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m029801 · Cited by 35
Genetic alterations of CCND1 and EMSY in breast cancers
Kirkegaard, T., Nielsen, K. V., Jensen, L., Campbell, F., Müller, S., Tovey, S., Brown, S., Cooke, T. G., & Bartlett, J. M. S. (2008) · Histopathology · doi:10.1111/j.1365-2559.2008.03007.x · Cited by 37
“Cyclin D1 is a cell cycle regulatory protein and a member of the cyclin D family, of which three members (cyclin D1, cyclin D2 and cyclin D3) have been identified to date.(5) The most widely recognized function of D cyclins is binding to and activation of cyclindependent kinases (CDK) 4 ⁄ 6, which is essential for dri…”
BackgroundFlint, M. S., Kim, G., Hood, B. L., Bateman, N. W., Stewart, N. A., & Conrads, T. P. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.05.008 · Cited by 36
“There is limited data in the literature on stress hormones and apoptosis (Herr et al., 2003; Moran et al., 2000; Sherr and Roberts, 2004; Wu et al., 2007).”
E2F-2 Promotes Nuclear Condensation and Enucleation of Terminally Differentiated Erythroblasts
Swartz, K. L., Wood, S. N., Murthy, T., Ramirez, O., Qin, G., Pillai, M. M., Rao, S., & Minella, A. C. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00274-16 · Cited by 36
Advances in the understanding and management of T-cell prolymphocytic leukemia
Laribi, K., Lemaire, P., Sandrini, J., & de Materre, A. B. (2017) · Oncotarget · doi:10.18632/oncotarget.22272 · Cited by 36
“Deletions in 12p13 that lead to haplo-insufficiency of the CDKN1B gene have been suggested to play a role in the pathogenesis of T-PLL, as this gene encodes the cyclin-dependent kinase inhibitory protein p27 (KIP1), which functions in cell-cycle regulation [43, 44].”
BackgroundWang, D., Wang, R., Huang, A., Fang, Z., Wang, K., He, M., Xia, J.-T., & Li, W. (2018) · Oncology Reports · doi:10.3892/or.2018.6703 · Cited by 40
“CCND1, a regulator of cell cycle (32,33), promotes tumor invasion and metastasis, according to evidence from clinical studies and in vivo experiments (34,35).”
Ramos‐García, P., González‐Moles, M. Á., Ayén, Á., González‐Ruiz, L., Montoya, J. A. G., & Ruiz‐Ávila, I. (2019) · Head & Neck · doi:10.1002/hed.25834 · Cited by 39
Sepúlveda, C., Murillo, O. I. N., Torres, A., Guzmán, L., & Wehinger, S. (2019) · Food Reviews International · doi:10.1080/87559129.2019.1649692 · Cited by 40
Moharil, R., Khandekar, S., Dive, A. M., & Bodhade, A. S. (2020) · Journal of Oral and Maxillofacial Pathology · doi:10.4103/jomfp.jomfp_164_20 · Cited by 39
“Journal of Oral and Maxillofacial Pathology | Volume 24 | Issue 2 | May-August 2020 phases of cell cycle is orchestrated by cyclins and cyclin‐ dependent kinases (CDKs) and by their inhibitors.[4,5] Cyclins are named such because they undergo a constant cycle of synthesis and degradation during cell division.”
BackgroundHow selective are clinical CDK4/6 inhibitors?
Hendrychová, D., Jorda, R., & Kryštof, V. (2020) · Medicinal Research Reviews · doi:10.1002/med.21769 · Cited by 38
“For example, these CDKs negatively modulate the activity of NFAT transcription factors, crucial regulators of T‐cell function.20 CDK4/6 also phosphorylate substrates affecting metabolic processes, cell differentiation, apoptosis, and mitochondrial activity.23–26 In addition, CDK4/6‐cyclin D complexes perform noncataly…”
BackgroundEmerging roles of lncRNA in Nasopharyngeal Carcinoma and therapeutic opportunities
Wang, H., Wang, W., & Fan, S. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.70292 · Cited by 37
“The CDK4 / cyclin D1 complex phosphorylates and inhibits the tumor suppressor protein retinoblastoma (RB), resulting in the release of E2F transcription factor, which regulates the gene expression required for S-phase entry and progression[72].”
BackgroundCcr4 Alters Cell Size in Yeast by Modulating the Timing of CLN1 and CLN2 Expression
Manukyan, A., Zhang, J., Thippeswamy, U., Yang, J., Zavala, N., Mudannayake, M. P., Asmussen, M., Schneider, C., & Schneider, B. L. (2008) · Genetics · doi:10.1534/genetics.108.086744 · Cited by 39
“Importantly, the basic yeast cell cycle machinery involved in regulating Start, including the G1-phase cyclin-dependent kinases (Cdks) that promote cell cycle progression, is highly conserved in mammalian cells (reviewed in Sherr and Roberts 2004; Cooper 2006).”
BackgroundCdk1 interplays with Oct4 to repress differentiation of embryonic stem cells into trophectoderm
Li, L., Wang, J., Hou, J., Wu, Z., Zhuang, Y., Lu, M., Zhang, Y., Zhou, X., Li, Z., Xiao, W., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.10.030 · Cited by 38
Zhang, X., Yu, S., Galson, D. L., Luo, M., Fan, J., Zhang, J., Guan, Y., & Xiao, G. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21888 · Cited by 36
Co-targeting BRAF and cyclin dependent kinases 4/6 for BRAF mutant cancers
Yadav, V., Chen, S.-H., Yue, Y. G., Buchanan, S. G., Beckmann, R. P., & Peng, S.-B. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.003 · Cited by 39
Olière, S., Arguello, M., Mésplède, T., Tumilasci, V. F., Nakhaei, P., Stojdl, D. F., Sonenberg, N., Bell, J. C., & Hiscott, J. B. (2008) · Journal of Virology · doi:10.1128/jvi.02601-07 · Cited by 36
Cyclin D2 is a GATA4 cofactor in cardiogenesis
Yamak, A., Latinkic, B., Dali, R., Temsah, R. M., & Nemer, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312993111 · Cited by 39
“D cyclins [Cyclin D1 (CycD1), CycD2, and CycD3] and their partners, the cyclin-dependent kinases (CDKs), are important regulators of the cell cycle (1), connecting the cell cycle machinery with the extracellular environment.”
BackgroundThe family of maize D‐type cyclins: genomic organization, phylogeny and expression patterns
Buendía‐Monreal, M., Rentería-Canett, I., Guerrero‐Andrade, O., Bravo‐Alberto, C. E., Martínez-Castilla, L. P., García, E., & Vázquez-Ramos, J. M. (2011) · Physiologia Plantarum · doi:10.1111/j.1399-3054.2011.01498.x · Cited by 37
Baydoun, H. H., Pancewicz, J., Bai, X., & Nicot, C. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-302 · Cited by 39
“Whereas cyclin D/cyclin dependent kinase (CDK) 4 and 6 control early G1, progression through G1/S is controlled by the cyclin E-CDK2 complexes.”
BackgroundInfluentialGeorgakis, G. V., Li, Y., Rassidakis, G. Z., Medeiros, L. J., & Younes, A. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.07.002 · Cited by 40
Feng, Z., Chen, J., Wei, H.-L., Gao, P. H., Shi, J.-S., Zhang, J., & Zhao, F. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.06.004 · Cited by 36
p21waf1/CIP1, a CDK inhibitor and a negative feedback system that controls macrophage activation
Lloberas, J., & Celada, A. (2009) · European Journal of Immunology · doi:10.1002/eji.200939262 · Cited by 36
Chondrogianni, N., Trougakos, I. P., Kletsas, D., Chen, Q. M., & Gonos, E. S. (2008) · Aging Cell · doi:10.1111/j.1474-9726.2008.00425.x · Cited by 37
“…the INK4 family that specifically inhibit the catalytic subunits of cdk4 and cdk6 kinases, and (ii) p21, p27 Kip1 (here-after referred to as p27) and p57 Kip2 proteins which are members of the Cip/Kip family that affect the activities of cyclin D, E-and A-dependent kinases (Sherr & Roberts, 2004).”
Yang, H., Yin, P., Shi, Z., Ma, Y., Zhao, C.-G., ZHENG, J., & Chen, T. (2015) · Oncology Letters · doi:10.3892/ol.2015.3838 · Cited by 35
Kurimchak, A., & Graña, X. (2015) · Cell Cycle · doi:10.4161/15384101.2014.985069 · Cited by 40
Yong-sheng, W., Feng, X., Jin, Y., Wu, Z., Hankey, W., Paisie, C. A., Li, L., Liu, F., Barsky, S. H., Zhang, W., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0213 · Cited by 37
“Most of these effects seem to occur because I3C induces a G1 cell cycle arrest (6–8) and has been shown to target multiple pathways to accomplish this, such as inhibiting Cdk6 gene expression by downregulating its promoter activity, disrupting the processing of cyclin E associated with the Cdk2 protein complex, and re…”
BackgroundInfluentialTargeted Therapies for Epstein-Barr Virus-Associated Lymphomas
Pei, Y., Wong, J. H.-Y., & Robertson, E. S. (2020) · Cancers · doi:10.3390/cancers12092565 · Cited by 37
“Cyclin D/CDK activity is also regulated by the CDK inhibitory proteins, including the INK4 (Inhibitors of CDK4) family (INK4A, INK4B, INK4C, and INK4D) and the CIP/KIP (CDK interacting protein/Kinase inhibitory protein) family (p21, p27, and p57) [19,24,25].”
BackgroundThe Status of Adjuvant and Neoadjuvant Melanoma Therapy, New Developments and Upcoming Challenges
Stege, H. M., Haist, M., Nikfarjam, U., Schultheis, M., Heinz, J., Pemler, S., Loquai, C., & Grabbe, S. (2021) · Targeted Oncology · doi:10.1007/s11523-021-00840-3 · Cited by 40
Hillion, S., Garaud, S., Devauchelle‐Pensec, V., Bordron, A., Berthou, C., Youinou, P., & Jamin, C. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02649.x · Cited by 43
Human Papillomavirus Infections: Warts or Cancer?
Chow, L. T., & Broker, T. R. (2013) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012997 · Cited by 37
Njaine, B., Martins, R. A. P., Santiago, M. F., Linden, R., & Silveira, M. S. (2010) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2010.07286.x · Cited by 35
“The time course of expression and activity of certain proteins is crucial to the control of cell cycle progression or cell cycle exit (Sherr & Roberts, 2004).”
BackgroundMoyse, E., Bauer, Š., Charrier, C., Coronas, V., Krantic, S. M., & Jean, A. (2006) · Autonomic Neuroscience · doi:10.1016/j.autneu.2006.03.006 · Cited by 35
The Initiation Step of Eukaryotic DNA Replication
Pospiech, H., Große, F., & Pisani, F. M. (2009) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-90-481-3471-7_5 · Cited by 44
The Role of CDKs and CDKIs in Murine Development
Campbell, G. J., Hands, E. L., & de Pette, M. V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155343 · Cited by 37
Bártek, J., & Lukas, J. (2011) · Nature · doi:10.1038/474171a · Cited by 38
Kröger, A., Stirnweiß, A., Pulverer, J. E., Klages, K., Grashoff, M., Reimann, J., & Häuser, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3564 · Cited by 41
Grishok, A., & Sharp, P. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508989102 · Cited by 39
Cell growth and the cell cycle: New insights about persistent questions
Øvrebø, J. I., Ma, Y., & Edgar, B. A. (2022) · BioEssays · doi:10.1002/bies.202200150 · Cited by 34
Targeting CDKs in cancer therapy: advances in PROTACs and molecular glues
Marei, H. E. S., Bedair, K., Hasan, A., Al-Mansoori, L., Gaiba, A., Morrione, A., Cenciarelli, C., & Giordano, A. (2025) · npj Precision Oncology · doi:10.1038/s41698-025-00931-8 · Cited by 42
Clinicopathological significance of tumor cyclin D1 expression in oral cancer
Ramos‐García, P., González‐Moles, M. Á., González‐Ruiz, L., Ayén, Á., Ruiz‐Ávila, I., Bravo, M., & Montoya, J. A. G. (2019) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2019.01.018 · Cited by 36
Sante, G. D., Pagé, J., Jiao, X., Nawab, O., Cristofanilli, M., Skordalakes, E., & Pestell, R. G. (2019) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2019.1615889 · Cited by 34
A major role of TWEAK/Fn14 axis as a therapeutic target for post-angioplasty restenosis
Méndez‐Barbero, N., Gutiérrez‐Muñoz, C., Madrigal‐Matute, J., Mínguez, P., Egido, J., Michel, J., Martín-Ventura, J. L., Esteban, V., & Blanco‐Colio, L. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.072 · Cited by 33
“G1 to S cell cycle progression is modulated by the balance between positive cell cycle regulators [cyclins and cyclin-dependent kinases (CDK)] on one hand and CDK inhibitors (CDKI) on the other [27].”
BackgroundYohannes, Y. B., Nakayama, S. M. M., Yabe, J., Nakata, H., Toyomaki, H., Kataba, A., Muzandu, K. M., Ikenaka, Y., Choongo, K., & Ishizuka, M. (2020) · Environmental Research · doi:10.1016/j.envres.2020.109759 · Cited by 33
van Harten, A. M., & Brakenhoff, R. H. (2021) · Cancers · doi:10.3390/cancers13112774 · Cited by 38
Targeting CDK7 in oncology: The avenue forward
Li, Z., Liu, G., Gao, Y., & Zhao, M. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108229 · Cited by 37
Hseu, Y., Lee, C.-C., Chen, Y.-C., Kumar, K. J. S., Chen, C., Huang, Y.-C., Hsu, L., Huang, H., & Yang, H. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.03.012 · Cited by 33
Contributions of Rad9 to tumorigenesis
Broustas, C. G., & Lieberman, H. B. (2012) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23424 · Cited by 34
Wang, Z. A., & Kalderon, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909272106 · Cited by 34
“Notable kinase-independent functions include stimulating the reentry of murine G0 cells into the cell cycle (21, 22).”
BackgroundMS4a4B, a CD20 Homologue in T Cells, Inhibits T Cell Propagation by Modulation of Cell Cycle
Xu, H., Yan, Y., Williams, M. S., Carey, G. B., Yang, J., Li, H., Zhang, G., & Rostami, A. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013780 · Cited by 38
“. Activation of CDKs requires the formation of CDK-cyclin complexes and is negatively regulated by two groups of CDK inhibitory proteins: Ink4 family (p16, p15, p18 and p19) and Cip/Kip family (p21, p27 and p57)”
BackgroundMolecular evolution of cyclin proteins in animals and fungi
Владимирович, Г. К., Suslov, V. V., Turnaev, I. I., Afonnikov, D. A., & Kolchanov, N. A. (2011) · BMC Evolutionary Biology · doi:10.1186/1471-2148-11-224 · Cited by 33
“Periodic changes in the concentration of cyclins cause sequential activation/inactivation of the CDK catalytic partners resulting in periodic advancement of cells through the cell cycle [2,5,6].”
BackgroundInfluentialComstock, C. E. S., & Knudsen, K. E. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4353 · Cited by 38
Follis, A. V., Galea, C. A., & Kriwacki, R. W. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0659-4_3 · Cited by 32
Iskusnykh, I. Y., Buddington, R. K., & Chizhikov, V. V. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.05.015 · Cited by 33
“In contrast, inhibitors of cyclin-dependent kinases (CDKIs) inhibit proliferation, promoting exit from the cell-cycle and differentiation (Sherr and Roberts, 2004; Starostina and Kipreos, 2012).”
Tout, I., Gomes, M., Ainouze, M., Marotel, M., Pecoul, T., Durantel, D., Vaccarella, S., Dubois, B., Loustaud-Ratti, V., Walzer, T., et al. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701726 · Cited by 32
“To assess whether HBValtered other CRE/CREB target genes in B cells, we analyzed the mRNA expression of cyclin D1 implicated in the cell cycle (23) and BCL-2 involved in B cell survival and apoptosis control (24).”
BackgroundCDK-mediated RNF4 phosphorylation regulates homologous recombination in S-phase
Luo, K., Deng, M., Li, Y., Wu, C., Xu, Z., Yuan, J., & Lou, Z. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv434 · Cited by 34
“One possibility is that the basal level of RNF4’s activity is sufficient for the regulation of NHEJ in G1/G2 phase while higher activity of RNF4 is important for HR in S-phase.”
BackgroundInfluentialFernández-Hernández, R., Rafel, M., Fusté, N. P., Ortiz, R. A., Casanova, J. M., Egea, J., Ferrezuelo, F., & Garí, E. (2013) · Cell Cycle · doi:10.4161/cc.25590 · Cited by 36
Zhu, Z., Jiang, W., McGinley, J. N., & Thompson, H. J. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91201.2008 · Cited by 35
Murray, T. V., Smyrnias, I., Schnelle, M., Mistry, R. K., Zhang, M., Beretta, M., Martin, D., Anilkumar, N. P., de Silva, S. M., Shah, A. M., et al. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.10.017 · Cited by 32
“consistent with the notion that the associated increase in cyclin D2 expression, seen upon Nox4 overexpression, is acting to promote the G1/S phase transition in the cardiomyocytes, as has been reported previously in other cell types [54].”
BackgroundGrimm, S. L., Contreras, A., Barcellos-Hoff, M.-H., & Rosen, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508167200 · Cited by 32
Differential Expression of D-Type Cyclins in HaCaT Keratinocytes and in Psoriasis
Belső, N., Széll, M., Pivarcsi, A., Kis, K., Kormos, B., Kenderessy, A. S., DOBOZY, A., Kemény, L. V., & Bata‐Csörgõ, Z. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701059 · Cited by 32
Schultz, K., Murthy, V., Tatro, J. B., & Beasley, D. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90393.2008 · Cited by 36
FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3α
Wierstra, I., & Alves, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.008 · Cited by 40
Cdk6 contributes to cytoskeletal stability in erythroid cells
Uras, I. Z., Scheicher, R., Kollmann, K., Glösmann, M., Prchal‐Murphy, M., Tigan, A.-S., Fux, D. A., Altamura, S., Neves, J., Muckenthaler, M. U., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.159947 · Cited by 31
“In the early G1 phase, cyclin-D-Cdk4/6 complexes phosphorylate and inactivate the retinoblastoma protein to activate E2F-dependent transcription.(1) Cdk4 and Cdk6 are 71% identical at the amino acid level, are ubiquitously expressed and bind all three D-type cyclins.”
Diverse roles for CDK‐associated activity during spermatogenesis
Palmer, N., Talib, S. Z. A., & Kaldis, P. (2019) · FEBS Letters · doi:10.1002/1873-3468.13627 · Cited by 31
Broad-spectrum antitumor properties of Withaferin A: a proteomic perspective
Dom, M. P., Berghe, W. V., & Ostade, X. V. (2020) · RSC Medicinal Chemistry · doi:10.1039/c9md00296k · Cited by 31
Origin of Cancer: Cell work is the Key to Understanding Cancer Initiation and Progression
Hanselmann, R. G., & Welter, C. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.787995 · Cited by 34
Nagappan, A., Park, K., Park, H. S., Kim, J. A., Hong, G. E., Kang, S. R., Lee, D. H., Kim, E. H., Lee, W. S., Won, C. K., et al. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.06.050 · Cited by 31
Post-mitotic role of the cell cycle machinery
Herrup, K. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.08.001 · Cited by 31
Corlu, A., & Loyer, P. (2012) · International Journal of Hepatology · doi:10.1155/2012/689324 · Cited by 31
“Independently, there was a demonstration that knockout mice for Cdk2 as well as for E-type Cyclins are viable and that the cell cycle of cultured Cdk2−/− mouse embryonic fibroblasts (MEFs) did not show major alterations [120–122].”
BackgroundEndoplasmic reticulum stress as a novel cellular response to di (2-ethylhexyl) phthalate exposure
Peropadre, A., Freire, P. F., Martín, J. M. P., Herrero, Ó., & Hazen, M. J. (2015) · Toxicology in Vitro · doi:10.1016/j.tiv.2015.10.009 · Cited by 31
“Regulation of G1-S transition depends initially on D-type cyclins (D1, D2, and/or D3) associated with CDK4/6 and later on cyclin E-CDK2 complexes (Sherr and Roberts, 2004).”
BackgroundParis, M., Wang, W., Shin, M.-H., Franklin, D. S., & ANDRISANI, O. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00575-06 · Cited by 32
“4B), consistent with the role of p27 as a cyclin/Cdk assembly or stability factor (66).”
BackgroundKollár, P., Bárta, T., Závalová, V. M., Šmejkal, K., & Hampl, A. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01171.x · Cited by 30
“Mammalian G1 cyclins and their associated cyclindependent kinases (CDKs) regulate cell division by communicating extracellular and intracellular mitogenic signals to the molecular machinery that drives the cell from G1 to S phase (Sherr and Roberts, 2004).”
BackgroundInfluentialShinderman‐Maman, E., Cohen, K., Moskovich, D., Hercbergs, A. H., Werner, H., Davis, P. J., Ellis, M. H., & Ashur‐Fabian, O. (2017) · Scientific Reports · doi:10.1038/s41598-017-16593-x · Cited by 33
González‐Ruiz, L., González‐Moles, M. Á., González‐Ruiz, I., Ruiz‐Ávila, I., & Ramos‐García, P. (2021) · Cancers · doi:10.3390/cancers13061314 · Cited by 33
“Cyclin D1, encoded by the CCND1 gene located on chromosome band 11q13, promotes cell cycle progression during the G1-S phase [6].”
BackgroundCyclin-dependent kinases in cancer: Role, regulation, and therapeutic targeting
Gupta, A., Dagar, G., Chauhan, R., Sadida, H. Q., Al-Marzooqi, S. K., Hashem, S., Shahab Uddin, M. S., Macha, M. A., Akil, A. S. A.-S., Pandita, T. K., et al. (2023) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2023.02.001 · Cited by 33
Jirawatnotai, S., Sharma, S., Michowski, W., Suktitipat, B., Geng, Y., Quackenbush, J. F., Elias, J. E., Gygi, S. P., Wang, Y. E., & Siciński, P. (2014) · Cell Cycle · doi:10.4161/15384101.2014.946850 · Cited by 30
“Cyclin D-CDK4/6 holoenzymes phosphorylate proteins governing cell cycle progression, such as the retinoblastoma protein, pRB.(1) Overexpression of cyclin D1 is found in several human cancer types, including breast cancers(2) colon cancers,(4,5) squamous cell carcinomas,(6) multiple myelomas,(7) and mantle cell lymphom…”
BackgroundVarma, H., Skildum, A. J., & Conrad, S. E. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001256 · Cited by 30
“. However, it is important to note that cdk2 is not essential for all cell cycle progression, since genetic knockout of cdk2 does not prevent somatic cell proliferation in mice”
BackgroundThe human papillomavirus type 11 E1^E4 protein is not essential for viral genome amplification
Fang, L., Budgeon, L. R., Doorbar, J., Briggs, E., & Howett, M. K. (2006) · Virology · doi:10.1016/j.virol.2006.01.051 · Cited by 42
Marnerides, A., Vassilakopoulos, T. P., Boltetsou, E., Levidou, G., Angelopoulou, M. K., Thymara, I., Kyrtsonis, M., Pappi, V., Tsopra, O. A., Panayiotidis, P. G., et al. (2011) · PubMed · Cited by 30
Evangelisti, C., Astolfi, A., Gaboardi, G. C., Tazzari, P. L., Pession, A., Goto, K., & Martelli, A. M. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.01.027 · Cited by 30
Meta-analysis reveals conserved cell cycle transcriptional network across multiple human cell types
Giotti, B., Joshi, A., & Freeman, T. C. (2017) · BMC Genomics · doi:10.1186/s12864-016-3435-2 · Cited by 32
“In contrast cycling cells have enough gene product to go through forthcoming cell cycles so reducing the overall time of the cell cycle [28].”
BackgroundInfluentialSignificance of cytoplasmic cyclin D1 expression in oral oncogenesis
Ramos‐García, P., Bravo, M., González‐Ruiz, L., & González‐Moles, M. Á. (2018) · Oral Diseases · doi:10.1111/odi.12752 · Cited by 30
Zanuy, M., Ramos‐Montoya, A., Villacañas, Ó., Canela-Canela, N., Miranda, A., Aguilar, E., Agell, N., Bachs, O., Rubio, J., Pujol, M. D., et al. (2011) · Metabolomics · doi:10.1007/s11306-011-0328-x · Cited by 34
“…and rate-limiting for the phosphorylation and inactivation of the tumor suppressor retinoblastoma protein (pRb) and the subsequent induction of the E2F-dependent transcriptional program required to enter the S-phase (Lundberg and Weinberg 1998; Malumbres et al. 2004; Sherr and Roberts 2004).”
Jiang, F., Hedaya, O. M., Khor, E., Wu, J., Auguste, M., & Yao, P. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad322 · Cited by 29
“Our results suggest that PRRC2B promotes cell proliferation by facilitating translation of CCND2 mRNA, which encodes the D-type cyclin facilitating G1/S transition in cancer and stem cells (35,45).”
Background
Metadata
- Authors
- Sherr, C. J., & Roberts, J. M.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2004-11-15
- Volume
- 18
- Issue
- 22
- Pages
- 2699-2711
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2152107294
- Cited by
- 1,089
- References
- 115
- Citations by year
- 2026: 13 · 2025: 36 · 2024: 48 · 2023: 38 · 2022: 34 · 2021: 42 · 2020: 49 · 2019: 50 · 2018: 36 · 2017: 35 · 2016: 42 · 2015: 51 · 2014: 47 · 2013: 52 · 2012: 62
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Howard Hughes Medical Institute
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Microtubule and mitosis dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- cyclin-dependent kinases, cyclins, D-type cyclins, G1 phase, cell cycle progression, CDK4, CDK6, CDK2, cyclin E, cyclin D, fetal development, mitogenic signaling
- MeSH terms
- Animals, Cell Cycle, Humans, Signal Transduction, Cyclins, Mice, Knockout, Cyclin-Dependent Kinases, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.